Plenary Session II: Discovery 2009

Session Type: ACR Plenary Sessions
Monday, October 19, 2009: 11:00 AM-12:30 PM
Ballroom AB (Pennsylvania Convention Center)
Moderators: Joel A. Block, MD, Rush University Medical Center and Ann E. Clarke, MD, McGill University Health Center
Papers:
11:00 AM
Introductory Talk
Mary K. Crow, M.D., Hospital for Special Surgery
11:15 AM
A Novel Autoantibody against 200/100 Kd Proteins Is Associated with Necrotizing Myopathy
Lisa Christopher-Stine, MD, MPH, Johns Hopkins University School of Medicine; Grace Hong, Johns Hopkins University School of Medicine; Livia Casciola-Rosen, PhD, Johns Hopkins University School of Medicine; Andrea M. Corse, Johns Hopkins University School of Medicine; Andrew Mammen, M.D., PhD, Johns Hopkins University School of Medicine
11:30 AM
Azathioprine Versus Mycophenolate Mofetil for Maintenance Immunosuppression of Proliferative Lupus Nephritis: Results of a Randomized Trial (MAINTAIN)
Frederic A. Houssiau, MD, Universite catholique Louvain; David P. D'Cruz, FRCP, Lupus Research Unit, The Rayne Institute, St Thomas' Hospital; Shirish R. Sangle, MBBCh, Lupus Research Unit, The Rayne Institute, St Thomas' Hospital; Philippe Remy, MD, Hôpital Henri Mondor; Carlos Vasconcelos, MD, Unidade de Imunologia Clínica - Hospital Santo António; Enrique de Ramon Garrido, MD, Hospital del SAS de Malaga; Inge-Margrethe Gilboe Sr., MD, Rikshospitalet; Isabelle Ravelingien, MD, Onze Lieve Vrouw Ziekenhuis; Maria Tektonidou, MD, University of Athens; Genevieve Depresseux, MD, Universite catholique Louvain; Loic P. Guillevin, MD, Hopital Cochin; Ricard Cervera, M, Autoimmune Diseases. Hospital Clínic
11:45 AM
Efficacy and Safety of Rituximab in Subjects with Active Proliferative Lupus Nephritis (LN): Results From the Randomized, Double-Blind Phase III LUNAR Study
R. Furie, MD, North Shore-LIJ Health System; R. J. Looney, MD, University of Rochester; B. Rovin, MD, Ohio State; Kevin M. Latinis, MD, PhD, KS Univ Med Ctr; G. Appel, MD, Columbia; J. Sanchez-Guerrero, MD, MS, Inst Nacional; F.C. Fervenza, MD, PhD, Mayo Clinic; R. Maciuca, PhD, Genentech; P. Brunetta, MD, Genentech, Inc.; D. Zhang, PhD, Genentech; J. Garg, MD, Genentech
12:00 PM
Combination Antibiotics as a Treatment for Chronic Chlamydia-Induced Reactive Arthritis
John D. Carter, MD, University of South Florida; Luis R. Espinoza, MD, LSU Medical Center; R.D. Inman, MD, Toronto Western Hospital; K.B. Sneed, PharmD, University of South Florida; Louis Ricca, M, University of South Florida; Frank B. Vasey, MD, University of South Florida; Joanne Valeriano, M, M.D., University of South Florida; J.A. Stanich, Wayne State University; C. Oszust, Wayne State University; H.C. Gerard, PhD, Wayne State University; Alan P. Hudson, PhD, Wayne State University
12:15 PM
Serial Re-Screening in High Risk Patients On Anti-TNF-&alpha Therapy Validate CDC Recommendations for Monitoring TB Risk
D. Cooray, MD, Harbor UCLA Med Ctr; R. Moran, FNP, Harbor UCLA Med Ctr; A. Broumand, M.D., Harbor UCLA Med Ctr; S. Bagheri, M.D., Harbor UCLA Med Ctr; J.S. Louie, M.D., University of California Los Angeles; DE Furst, MD, University of California Los Angeles; GA Karpouzas, M.D., Harbor UCLA Med Ctr
See more of: ACR Plenary Sessions

To see other sessions for this day, use the date buttons to the left.